InsightAce Analytic Pvt. Ltd. reveals the release of a market assessment report on the Global AI-based Clinical Trial Solution Providers Market Trends, Industry Competition Analysis, Revenue and Forecast To 2030. According to InsightAce Analytic's most recent research, the global market for AI-based clinical trial solution providers is predicted to grow rapidly over the forecast period. By geography, North America is likely to lead the market.

Clinical trial protocols and research rely heavily on artificial intelligence. AI-powered platforms improve clinical data interpretability and contribute to the resolution of huge and complicated difficulties in clinical research and medical product development. AI platforms enable researchers to examine new compounds and therapeutics in silico.

Advanced digital and medical technologies, rapid innovation of new AI-based platforms/systems, high prevalence of chronic and infectious diseases, increased healthcare expenditure, rising government investments for R&D of clinical trials, increasing use of AI and machine learning techniques, and rising awareness among researchers about AI platforms are expected to boost market growth in the forecast years. Furthermore, biopharmaceutical companies fuel growth in the market for AI-based clinical trial solution providers, since the majority of these organizations choose to speed clinical trials using AI platforms and sophisticated planning and design approaches.

However, rigorous rules governing AI-based clinical trial approvals, as well as a lack of awareness of AI applications or platforms, are projected to limit market growth possibilities over the projection period (2020-2030). Geographically, North America dominated the AI-based clinical trial solution providers market in 2020 and will continue to do so over the estimated timeframe, followed by Europe, owing to rising human health diseasse, rapid adoption of new techniques, and increased clinical R&D funding by the government. The Asia-Pacific region is expected to grow this market in the next years as clinical trials and research investments increase.

Source: https://www.openpr.com/news/3788443/ai-based-clinical-trial-solution-providers-market-top-players